Previous Close | 5.07 |
Open | 5.00 |
Bid | 5.02 x N/A |
Ask | 5.06 x N/A |
Day's Range | 5.00 - 5.07 |
52 Week Range | 3.40 - 6.02 |
Volume | |
Avg. Volume | 778,335 |
Market Cap | 3.486B |
Beta (5Y Monthly) | 0.75 |
PE Ratio (TTM) | 502.00 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Dec 08, 2022 |
1y Target Est | N/A |
As global markets experience broad-based gains and U.S. indexes approach record highs, investors are navigating a landscape marked by geopolitical tensions and economic uncertainties. Amidst these conditions, identifying undervalued stocks can be a strategic move for those looking to capitalize on potential market inefficiencies.
Find insight on Novartis, Valneva, Ryman Healthcare and more in the latest Market Talks covering the Health Care sector.